pT3-EF1aH Yap S127A Citations (8)
Originally described in: Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma.Tschaharganeh DF, Chen X, Latzko P, Malz M, Gaida MM, Felix K, Ladu S, Singer S, Pinna F, Gretz N, Sticht C, Tomasi ML, Delogu S, Evert M, Fan B, Ribback S, Jiang L, Brozzetti S, Bergmann F, Dombrowski F, Schirmacher P, Calvisi DF, Breuhahn K Gastroenterology. 2013 Jun;144(7):1530-1542.e12. doi: 10.1053/j.gastro.2013.02.009. Epub 2013 Feb 16. PubMed Journal
Articles Citing pT3-EF1aH Yap S127A
| Articles |
|---|
| Mouse Model for Hepatocellular Carcinoma and Cholangiocarcinoma Originated from Mature Hepatocytes. Yamamoto M, Xin B, Nishikawa Y. Methods Mol Biol. 2019;1905:221-236. doi: 10.1007/978-1-4939-8961-4_20. PubMed |
| Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling. Delgado ER, Erickson HL, Tao J, Monga SP, Duncan AW, Anakk S. Mol Cell Biol. 2021 Mar 24;41(4). pii: MCB.00596-20. doi: 10.1128/MCB.00596-20. Print 2021 Mar 24. PubMed |
| Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, Decker A, Worley J, Caviglia JM, Yu L, Yin D, Saito Y, Savage T, Wells RG, Mack M, Zender L, Arpaia N, Remotti HE, Rabadan R, Sims P, Leblond AL, Weber A, Riener MO, Stockwell BR, Gaublomme J, Llovet JM, Kalluri R, Michalopoulos GK, Seki E, Sia D, Chen X, Califano A, Schwabe RF. Cancer Cell. 2021 Jun 14;39(6):866-882.e11. doi: 10.1016/j.ccell.2021.03.012. Epub 2021 Apr 29. PubMed |
| Geospatial Immune Heterogeneity Reflects the Diverse Tumor-Immune Interactions in Intrahepatic Cholangiocarcinoma. Lin Y, Peng L, Dong L, Liu D, Ma J, Lin J, Chen X, Lin P, Song G, Zhang M, Liu Y, Rao J, Wei C, Lu Y, Zhang S, Ding G, Peng Z, Lu H, Wang X, Zhou J, Fan J, Wu K, Gao Q. Cancer Discov. 2022 Oct 5;12(10):2350-2371. doi: 10.1158/2159-8290.CD-21-1640. PubMed |
| Multiomics characterization of mouse hepatoblastoma identifies yes-associated protein 1 target genes. Rodriguez TC, Kwan SY, Smith JL, Dadafarin S, Wu CH, Sontheimer EJ, Xue W. Hepatology. 2022 Aug 6. doi: 10.1002/hep.32713. PubMed |
| METTL3-Mediated m6A Modification Regulates the Polycomb Repressive Complex 1 Components BMI1 and RNF2 in Hepatocellular Carcinoma Cells. Chen W, Zhang J, Ma W, Liu N, Wu T. Mol Cancer Res. 2025 Mar 3;23(3):190-201. doi: 10.1158/1541-7786.MCR-24-0362. PubMed |
| Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice. Chen S, Huang C, Li K, Cheng M, Zhang C, Xiong J, Tian G, Zhou R, Ling R, Wang X, Xiong G, Zhang Z, Ma J, Zhu Y, Zhou B, Peng L, Peng Z, Li H, Chen D. J Clin Invest. 2025 Jan 7;135(5):e180893. doi: 10.1172/JCI180893. PubMed |
| Phosphoglycerate dehydrogenase stabilizes protein kinase C delta type mRNA to promote hepatocellular carcinoma progression. Cheng B, Peng P, Chen S, Liu R, Li X, Wang K, Ma J, Wang K, Tang N, Huang A. Signal Transduct Target Ther. 2025 Jul 18;10(1):236. doi: 10.1038/s41392-025-02304-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.